Financials

  • Market Capitalization 14.54 M
  • Employee 24
  • Founded 2017
  • CEO N/A
  • Website www.passagebio.com
  • Headquarter Delaware, United States
  • FIGI BBG00NBK4XF9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.82
Price to sales ratio
25.52

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4660
LSTA
Lisata Therapeutics, Inc. - Common Stock
1.69 USD-7.14%+3.68%+56.48%-25.55%15.23 M USD
4669
ADIL
Adial Pharmaceuticals, Inc - Common Stock
5.60 USD-1.58%-9.53%+78.91%+1335.90%14.70 M USD
4688
INTS
Intensity Therapeutics, Inc. - Common Stock
4.25 USD-0.47%-7.00%-1.39%+1417.86%13.88 M USD
4696
NRSN
NeuroSense Therapeutics Ltd. - Ordinary Shares
0.42 USD-4.55%+10.53%-12.50%-60.00%13.67 M USD

Frequently asked questions about Passage Bio, Inc. Common Stock

What is the Passage Bio, Inc. Common Stock stock price today?

The current price of Passage Bio, Inc. Common Stock (PASG) is 4.52. Over the past 24 hours, the stock has changed by +4.39%. Follow the PASG chart for real-time price dynamics.

What is the stock ticker of Passage Bio, Inc. Common Stock?

Passage Bio, Inc. Common Stock trades under the ticker PASG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Passage Bio, Inc. Common Stock stock going up?

PASG has changed by -3.00% over the last week, +0.89% over the last month, and -48.87% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Passage Bio, Inc. Common Stock?

Passage Bio, Inc. Common Stock currently has a market capitalization of 14.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Passage Bio, Inc. Common Stock earnings last quarter?

Last quarter, Passage Bio, Inc. Common Stock reported earnings of -2.44 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Passage Bio, Inc. Common Stock revenue for the last quarter?

Passage Bio, Inc. Common Stock reported quarterly revenue of 200 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Passage Bio, Inc. Common Stock net income for the last quarter?

Passage Bio, Inc. Common Stock reported net income of -7.82 M for the last quarter. The previous quarter showed -7.56 M, which means net income changed by -3.47%.

How many employees does Passage Bio, Inc. Common Stock have?

As of the latest available data, Passage Bio, Inc. Common Stock has 24 employees. Workforce size can provide additional context about the company's scale and operations.

What is Passage Bio, Inc. Common Stock EBITDA?

Passage Bio, Inc. Common Stock EBITDA is -6.47 M, and its EBITDA margin is -3 236.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Passage Bio, Inc. Common Stock stock?

You can buy Passage Bio, Inc. Common Stock (PASG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Passage Bio, Inc. Common Stock stock?

Investing in Passage Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PASG chart and related analysis on metatrader.com as part of your research.

News